Time-Resolved FRET-Based Assays to Characterize G Protein-Coupled Receptor Hetero-oligomer Pharmacology.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2019
Historique:
entrez: 11 4 2019
pubmed: 11 4 2019
medline: 3 8 2019
Statut: ppublish

Résumé

Although G protein-coupled receptor (GPCR) oligomerization is a matter of debate, it has been shown that the nature of the GPCR partners within the oligomers can influence the pharmacological properties of the receptors. Therefore, finding specific ligands for homo- or hetero-oligomers opens new perspectives for drug discovery. However, no efficient experimental strategy to screen for such ligands existed yet. Indeed, conventional binding strategies do not discriminate ligand binding on GPCR monomers, homo- or hetero-oligomers. To address this issue, we recently developed a new assay based on a time-resolved FRET method that is easy to implement and that can focus on ligand binding specifically on the hetero-oligomer.

Identifiants

pubmed: 30969415
doi: 10.1007/978-1-4939-9121-1_8
doi:

Substances chimiques

Ligands 0
Receptors, G-Protein-Coupled 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

151-168

Auteurs

Joyce Heuninck (J)

CNRS, UMR 5203, Institut de Génomique Fonctionnelle, Montpellier, France.
INSERM, U. 1191, Montpellier, France.
Université de Montpellier, Montpellier, France.

Candide Hounsou (C)

CNRS, UMR 5203, Institut de Génomique Fonctionnelle, Montpellier, France.
INSERM, U. 1191, Montpellier, France.
Université de Montpellier, Montpellier, France.

Elodie Dupuis (E)

Cisbio, Codolet, France.

Eric Trinquet (E)

Cisbio, Codolet, France.

Bernard Mouillac (B)

CNRS, UMR 5203, Institut de Génomique Fonctionnelle, Montpellier, France.
INSERM, U. 1191, Montpellier, France.
Université de Montpellier, Montpellier, France.

Jean-Philippe Pin (JP)

CNRS, UMR 5203, Institut de Génomique Fonctionnelle, Montpellier, France.
INSERM, U. 1191, Montpellier, France.
Université de Montpellier, Montpellier, France.

Dominique Bonnet (D)

Laboratoire d'Innovation Thérapeutique, Faculté de Pharmacie, UMR7200 CNRS/Université de Strasbourg, LabEx MEDALIS, Illkirch, France. dominique.bonnet@unistra.fr.

Thierry Durroux (T)

CNRS, UMR 5203, Institut de Génomique Fonctionnelle, Montpellier, France. tdurroux@igf.cnrs.fr.
INSERM, U. 1191, Montpellier, France. tdurroux@igf.cnrs.fr.
Université de Montpellier, Montpellier, France. tdurroux@igf.cnrs.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH